Artículo
3D-QSAR design of novel antiepileptic sulfamides
Gavernet, Luciana
; Domínguez Cabrera, María Josefina; Bruno Blanch, Luis Enrique; Estiu, Guillermina Lucia
Fecha de publicación:
01/02/2007
Editorial:
Pergamon-Elsevier Science Ltd
Revista:
Bioorganic & Medicinal Chemistry
ISSN:
0968-0896
e-ISSN:
1464-3391
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
A three-dimensional quantitative structure-activity relationship method, the comparative molecular field analysis (CoMFA), was applied to design new anticonvulsant symmetric sulfamides. The training set (27 structures) was comprised by traditional and new-generation anticonvulsant (AC) ligands that exhibit a potent activity in MES test. Physicochemical determinants of binding, such as steric and electrostatic properties, were mapped onto the molecular structures of the set, in order to interpret graphically the CoMFA results in terms of field contribution maps. The 3D-QSAR models demonstrate a good ability to predict the activity of the designed compounds (r2 = 0.967, q2 = 0.756).
Palabras clave:
ANTICONVULSANT DRUGS
,
COMFA
,
DRUG DESIGN
,
SULFAMIDES
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(CCT - LA PLATA)
Articulos de CTRO.CIENTIFICO TECNOL.CONICET - LA PLATA
Articulos de CTRO.CIENTIFICO TECNOL.CONICET - LA PLATA
Citación
Gavernet, Luciana; Domínguez Cabrera, María Josefina; Bruno Blanch, Luis Enrique; Estiu, Guillermina Lucia; 3D-QSAR design of novel antiepileptic sulfamides; Pergamon-Elsevier Science Ltd; Bioorganic & Medicinal Chemistry; 15; 3; 1-2-2007; 1556-1567
Compartir
Altmétricas